Yesterday's news that Invitrogen is buying Applied Biosystems for $6.7 billion stirred tremendous interest from the community. Our sister website GenomeWeb Daily News reports that "the deal would be the largest in the life sciences tools market since Thermo Electron bought Fisher Scientific for $10.6 billion in 2006." Invitrogen CEO Greg Lucier will head up the whole company, and current Applera CEO Tony White will be a consultant for five years once the deal is approved.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.